Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
13.84
-0.94 (-6.36%)
Mar 31, 2025, 10:09 AM EDT - Market open
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.01 billion as of March 31, 2025. Its market cap has decreased by -30.90% in one year.
Market Cap
2.01B
Enterprise Value
1.01B
1-Year Change
-30.90%
Ranking
Category
Stock Price
$13.84
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.01B, an increase of 6.50%. That is a compound annual growth rate of 0.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |